Histomorphometric analysis in hpv-induced cervical lesions

[1]  Youzhong Zhang,et al.  Involvement of Human Papillomaviruses in Cervical Cancer , 2018, Front. Microbiol..

[2]  B. Lü,et al.  Tumor-infiltrating CD8+ and FOXP3+ lymphocytes before and after neoadjuvant chemotherapy in cervical cancer , 2018, Diagnostic Pathology.

[3]  A. Biete,et al.  Impact of systemic inflammation biomarkers on the survival outcomes of cervical cancer patients , 2018, Clinical and Translational Oncology.

[4]  D. Aebersold,et al.  Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation , 2018, Radiation oncology.

[5]  P. Zhou,et al.  Analysis of cervical human papillomavirus infection in 2300 women in Urumqi, China , 2018, Medicine.

[6]  R. Cobucci,et al.  Th17 response in patients with cervical cancer , 2018, Oncology letters.

[7]  Yuerong Liang,et al.  Suppressive Effects of EGCG on Cervical Cancer , 2018, Molecules.

[8]  S. Witkin,et al.  Immune Response to Human Papillomavirus One Year after Prophylactic Vaccination with AS04-Adjuvanted HPV-16/18 Vaccine: HPV-Specific IgG and IgA Antibodies in the Circulation and the Cervix , 2018, Asian Pacific journal of cancer prevention : APJCP.

[9]  Yi Zhang,et al.  Diagnostic Utility of HPV16 E6 mRNA or E7 mRNA Quantitative Expression for Cervical Cells of Patients with Dysplasia and Carcinoma , 2018, Cell transplantation.

[10]  S. Al Awar,et al.  Frequency of rare and multi viral high-risk HPV types infection in cervical high grade squamous intraepithelial lesions in a non-native dominant middle eastern country: a polymerase chain reaction-based pilot study , 2018, Diagnostic Pathology.

[11]  Yoshiaki Ito,et al.  High-Risk Human Papillomaviral Oncogenes E6 and E7 Target Key Cellular Pathways to Achieve Oncogenesis , 2018, International journal of molecular sciences.

[12]  Feipeng Zhao,et al.  Detailed analysis of inflammatory cell infiltration and the prognostic impact on nasopharyngeal carcinoma , 2018, Head & neck.

[13]  G. Glab,et al.  Telomeres and Telomerase During Human Papillomavirus-Induced Carcinogenesis , 2018, Molecular Diagnosis & Therapy.

[14]  A. Tschirley,et al.  Microparticles produced by human papillomavirus type 16 E7-expressing cells impair antigen presenting cell function and the cytotoxic T cell response , 2018, Scientific Reports.

[15]  J. Fregnani,et al.  Trend analysis of the quality indicators for the Brazilian cervical cancer screening programme by region and state from 2006 to 2013 , 2018, BMC Cancer.

[16]  G. Marone,et al.  Eosinophils: The unsung heroes in cancer? , 2018, Oncoimmunology.

[17]  Sandip Mukhopadhyay,et al.  An Altered Ratio of CD4+ And CD8+ T Lymphocytes in Cervical Cancer Tissues and Peripheral Blood – A Prognostic Clue? , 2018, Asian Pacific journal of cancer prevention : APJCP.

[18]  G. Yazici,et al.  Prognostic Significance of Indicators of Systemic Inflammatory Responses in Glioblastoma Patients , 2017, Asian Pacific journal of cancer prevention : APJCP.

[19]  S. Smola.  Immunopathogenesis of HPV-Associated Cancers and Prospects for Immunotherapy , 2017, Viruses.

[20]  I. Frazer,et al.  Modulation of antigen presenting cell functions during chronic HPV infection , 2017, Papillomavirus research.

[21]  J. Lee,et al.  The Neutrophil-Lymphocyte Ratio Predicts Recurrence of Cervical Intraepithelial Neoplasia , 2017, Journal of Cancer.

[22]  A. Quaas,et al.  Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma , 2017, Oncotarget.

[23]  Yan-hong Yu,et al.  Prognostic significance of neutrophil-to-lymphocyte ratio in cervical cancer: A systematic review and meta-analysis of observational studies , 2017, Oncotarget.

[24]  P. Shuai,et al.  ADAR1 overexpression is associated with cervical cancer progression and angiogenesis , 2017, Diagnostic Pathology.

[25]  B. C. Das,et al.  Knowledge, Awareness and Attitude on HPV, HPV Vaccine and Cervical Cancer among the College Students in India , 2016, PloS one.

[26]  Zhangguo Chen,et al.  Squamous cell carcinomas escape immune surveillance via inducing chronic activation and exhaustion of CD8+ T Cells co-expressing PD-1 and LAG-3 inhibitory receptors , 2016, Oncotarget.

[27]  M. Preusser,et al.  Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer , 2016, Clinical & Experimental Metastasis.

[28]  A. Bateman,et al.  Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma , 2016, Cancer Immunology, Immunotherapy.

[29]  Fei-yun Zheng,et al.  Cervical cancer systemic inflammation score: a novel predictor of prognosis , 2016, Oncotarget.

[30]  Wen‐Chun Chang,et al.  Regulatory T Cells Suppress Natural Killer Cell Immunity in Patients With Human Cervical Carcinoma , 2015, International Journal of Gynecologic Cancer.

[31]  J. Mei,et al.  The infiltration and functional regulation of eosinophils induced by TSLP promote the proliferation of cervical cancer cell. , 2015, Cancer letters.

[32]  B. Monk,et al.  New Strategies in Advanced Cervical Cancer: From Angiogenesis Blockade to Immunotherapy , 2014, Clinical Cancer Research.

[33]  C. Anton,et al.  Potential value of in situ cellular immune response in HPV subtype 16 and 18 positive cervical cancer. , 2014, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.

[34]  R. M. Etchebehere,et al.  Local Lymphocytes and Nitric Oxide Synthase in the Uterine Cervical Stroma of Patients with Grade III Cervical Intraepithelial Neoplasia , 2010, Clinics.

[35]  N. Wadhwa,et al.  Eosinophils as a marker for invasion in cervical squamous neoplastic lesions. , 2003, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[36]  A. Zwinderman,et al.  Presence of an eosinophilic infiltrate in cervical squamous carcinoma results from a type 2 immune response. , 1999, Gynecologic oncology.

[37]  A. Zwinderman,et al.  Tumor-associated eosinophilic infiltrate of cervical cancer is indicative for a less effective immune response. , 1996, Human pathology.